The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
Lam
H C
HC
Li
S H
SH
Wang
J T
JT
Tang
K T
KT
Ho
L T
LT
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D048909:Diabetes Complications; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000960:Hypolipidemic Agents; C005681:alfibrate; D002995:Clofibric Acid; D002994:Clofibrate